Nanoviricides Inc Q1 2018 Institutional Investor Sentiment Better Than Expected

July 12, 2018 - By Margaret Downey

Sentiment for Nanoviricides Inc (NYSEMKT:NNVC)

Nanoviricides Inc (NYSEMKT:NNVC) institutional sentiment increased to 1 in Q1 2018. Its up 0.10, from 0.9 in 2017Q4. The ratio increased, as 11 hedge funds started new and increased stock positions, while 11 sold and decreased stock positions in Nanoviricides Inc. The hedge funds in our partner’s database now own: 3.49 million shares, up from 3.14 million shares in 2017Q4. Also, the number of hedge funds holding Nanoviricides Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 5 Reduced: 6 Increased: 8 New Position: 3.

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company has market cap of $28.79 million. The firm is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus drug candidate that could enable a functional cure for HIV/AIDS. It currently has negative earnings. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses.

The stock increased 12.60% or $0.0467 during the last trading session, reaching $0.4173. About 30,693 shares traded. NanoViricides, Inc. (NYSEMKT:NNVC) has declined 62.21% since July 12, 2017 and is downtrending. It has underperformed by 74.78% the S&P500.

Pioneer Trust Bank N A Or holds 0.04% of its portfolio in NanoViricides, Inc. for 100,000 shares. Wharton Business Group Llc owns 363,513 shares or 0.03% of their US portfolio. Moreover, A.R.T. Advisors Llc has 0% invested in the company for 17,466 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Bank Of New York Mellon Corp, a New York-based fund reported 39,348 shares.

NanoViricides, Inc. (NYSEAMERICAN:NNVC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: